Important note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
 |
New Vision (Kampala) - September 1, 2008
Anthony Bugembe and Charles Ariko
As of August 19, there were no stocks for the life-prolonging AIDS drugs at the ministry.
A total of 66,950 patients are on the programme and of these, 2,498 are children.
Martin Oteba, the acting assistant commissioner for health services in charge of pharmaceuticals, last evening told The New Vision that they had placed orders for more drugs from Quality Chemicals.
"One of the directors informed me that the drugs are already in the country awaiting clearance at the airport. Most likely, they will be delivered tomorrow (today)," he said.
Last month, the Government ordered for ARVs worth $1.8m (sh3b) from Quality Chemicals.
The company based in Luzira, a Kampala suburb, entered a joint venture with CIPLA, a leading Indian pharmaceutical firm, to produce the drugs and sell them at subsidised rates.
Other consignments of ARVs are expected from UNICEF, the Global Fund and the Clinton Foundation.
The ministry will require $180,000 (sh293m) to clear, store and distribute the donated drugs.
This financial year, the Government set aside sh60b to purchase the AIDS drugs.
080901
NV080901
Copyright © 2008 - The New Vision. All articles are republished on AEGIS by permission. Material may not be redistributed, posted to any other location, published or used for broadcast without written authorization from Managing Director/Editor-in-chief, The New Vision, P.O. Box 9815, Kampala - Uganda, Tel/fax: 256-41-235221, E-mail: wpike@newvision.co.ug.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .